Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Shares of Moderna (NASDAQ:MRNA) jumped 5% following reports that it had been awarded $590 million for the development of a bird flu vaccine. The funding, provided by the Department of Health and Human ...

Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. Read more at straitstimes.com.

HHS is investing more than $800 million in vaccine development and manufacturing capacity to strengthen the nation's response capabilities to emerging infectious disease threats, including bird flu.

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

As fears grow of a possible bird flu pandemic in humans, the federal government is pouring more money into the development of ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business ...

“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...

Due to ongoing sporadic H5N1 avian flu infections and brisk levels of seasonal flu activity, the US Centers for Disease ...

The company's newer product, an RSV ( respiratory syncytial virus) vaccine, has also underperformed, contributing "minimal ...

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...